Sign up
Healthed-White-on-Blue
elef

Eleftheria Kodosaki

Research Associate in Neuroimmunology, Cardiff University
BSc (hons/1st) in Biology (National and Kapodistrian University of Athens, Greece), MSc in cognitive neuroscience (Aston University, UK), and PhD in neuroimmunology (Cardiff Metropolitan University, UK).Interested in the biology of neuroinflammation and neurodegeneration, and especially in how certain factors can push an inflamed brain towards neurological or psychiatric disorders.In the past I have investigated the changes of certain immune system biomarkers which are observed in patients with Multiple Sclerosis and Covid-19, while currently my focus has shifted to the immune basis of psychosis.

More from this expert

jd-mason-cKT0oJL9vMI-unsplash

New Alzheimer’s drug: what you need to know about donanemab’s promising trial results

American pharmaceutical company Eli Lilly announced last week that it had seen

By Eleftheria Kodosaki
Clinical Articles iconClinical Articles

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

Cardiovascular Risk and Fatty Liver Disease

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

A/Prof William Kemp

Gastroenterologist and Hepatologist; Alfred Hospital Melbourne, Monash University School of Translational Medicine

We invite you to our next free webcast, where I will discuss cardiovascular risk and fatty liver disease. Earn up to 4 hours CPD. RACGP & ACRRM accredited.

Register for this webcast